Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

GSK Educational Grant Helps Foster Education and Innovation in Caring for Edentulous Patients

GSK Educational Grant Helps Foster Education and Innovation in Caring for Edentulous Patients PITTSBURGH – (July 1, 2009) –GlaxoSmithKline Consumer Healthcare announces the release of new data on the future of edentulism, highlighting the key roles dental professionals must play

GSK Educational Grant Helps Foster Education and Innovation in Caring for Edentulous Patients


PITTSBURGH – (July 1, 2009) –GlaxoSmithKline Consumer Healthcare announces the release of new data on the future of edentulism, highlighting the key roles dental professionals must play in providing quality oral healthcare and emotional support to denture patients. The research, funded through an educational grant from GlaxoSmithKline Consumer Healthcare, was originally presented at the Federation Dentaire International (FDI) World Congress and was recently published by the American College of Prosthodontists (ACP) in its March issue of the Journal of Prosthodontics.

The results of the research show the psychological impact the denture process can have on patients, and underscore the need for dental professionals to provide both emotional support and education throughout the process. The research, performed by doctors from the University of North Carolina School of Dentistry, the Mayo Clinic, Glasgow Dental Hospital and School, and the UCLA School of Dentistry, cites data showing that increasing life expectancies and the size of the aging population will result in a sustained demand for dentures over the coming years. While dental implants are becoming more popular, the researchers caution that not every patient is a good candidate and many cannot afford the procedure, meaning that dentures will remain an important treatment for edentulism.
 
“Dentistry has left a significant and growing number of patients behind,” writes Dr. Jonathan Ferencz in an introduction to the research within the Journal of Prosthodontics. Dr. Ferencz cites the increasing number of edentulous patients, lack of technological improvements to dentures, declining denture curriculum in schools, and practicing dentists’ loss of interest in the field as factors in a “perfect storm” that is threatening quality care.
 
Additional highlights from the work show that denture wearers are at risk for multiple oral and systemic disorders, reinforcing the need for careful treatment and regular recall visits. Furthermore, one paper outlines the serious emotional impact that receiving dentures can have on a patient’s life and concludes that determining patient expectations prior to treatment is critical. Additionally, data shows that use of a denture adhesive can help improve patient acceptance and adaptation to new dentures, easing the transition process for patients.
 
The new data complements earlier research performed by GlaxoSmithKline Consumer Healthcare on helping patients transition to life with dentures and properly care for them. Those studies showed that use of Polident® cleanser helped keep denture surfaces smooth, limiting the growth of bacteria and helping to keep dentures odor-free. Another study on Super PoliGrip® adhesive found the product beneficial even for well-fitting dentures, with patients reporting increased confidence, comfort and satisfaction when using the adhesive.
 
“As the baby boomer population ages, the demographics of denture patients are expected to shift, and it is imperative for dentists to be prepared to work with this changing population,” said Eric Sensky, GlaxoSmithKline Denture Care Brand Manager. “GlaxoSmithKline is dedicated to helping dental professionals serve these patients and assist them with feeling comfortable and confident with their dentures.”
 
GlaxoSmithKline Consumer Healthcare, a leader in the development of denture care products, is committed to raising awareness of the needs of edentulous patients. As part of that commitment, GSK is proud to work with the leading researchers in edentulism studies to foster education and innovation. By partnering with the ACP, GSK hopes to make the most innovative and relevant information accessible to dental professionals world wide.

For more information about this data please visit www.dental-professional.com.

###


About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the products alli, Nicorette, NicoDerm CQ, Commit, Abreva, Aquafresh, Sensodyne, and TUMS, trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline is one of the world’s leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Get 10% Off "Implant Therapy and Strategies for Behavior Change" Live CE Webinar

VIPMC524
Coupon has expired

Your exclusive code is ready! Copy it now and then visit our CE Library to add the webinar to your cart.

MasterClass Webinar Discount